المؤلفون: Wall MA; Institute for Systems Biology, Seattle, WA, USA., Turkarslan S; Institute for Systems Biology, Seattle, WA, USA., Wu WJ; Institute for Systems Biology, Seattle, WA, USA., Danziger SA; Bristol-Myers Squibb, Summit, NJ, USA., Reiss DJ; Bristol-Myers Squibb, Summit, NJ, USA., Mason MJ; Sage Bionetworks, Seattle, WA, USA., Dervan AP; Bristol-Myers Squibb, Summit, NJ, USA., Trotter MWB; Celgene Institute for Translational Research Europe (CITRE), a Bristol-Myers Squibb Company, Summit, NJ, USA., Bassett D; Bristol-Myers Squibb, Summit, NJ, USA., Hershberg RM; Celgene Corporation, Seattle, WA, USA., Lomana ALG; Institute for Systems Biology, Seattle, WA, USA. adrian.lopezgarciadelomana@isbscience.org., Ratushny AV; Bristol-Myers Squibb, Summit, NJ, USA. alexander.ratushnyy@bms.com., Baliga NS; Institute for Systems Biology, Seattle, WA, USA. nitin.baliga@isbscience.org.; Departments of Biology, Microbiology, and Molecular Engineering Sciences, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Lawrence Berkeley National Labs, Berkeley, CA, USA. nitin.baliga@isbscience.org.

المصدر: NPJ precision oncology [NPJ Precis Oncol] 2021 Jun 28; Vol. 5 (1), pp. 60. Date of Electronic Publication: 2021 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

المؤلفون: Danziger SA; Bristol Myers Squibb, Seattle, Washington, United States of America., McConnell M; Bristol Myers Squibb, Seattle, Washington, United States of America., Gockley J; Sage Bionetworks, Seattle, Washington, United States of America., Young MH; Sage Bionetworks, Seattle, Washington, United States of America., Rosenthal A; Cancer Research and Biostatistics, Seattle, Washington, United States of America., Schmitz F; Sage Bionetworks, Seattle, Washington, United States of America., Reiss DJ; Bristol Myers Squibb, Seattle, Washington, United States of America., Farmer P; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Alapat DV; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Singh A; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Ashby C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Bauer M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Ren Y; Bristol Myers Squibb, Seattle, Washington, United States of America., Smith K; Bristol Myers Squibb, Seattle, Washington, United States of America., Couto SS; Genmab, Princeton, New Jersey, United States., van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Davies F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Zangari M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Petty N; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Dhodapkar MV; Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America., Copeland WB; Bristol Myers Squibb, Seattle, Washington, United States of America., Fox B; Bristol Myers Squibb, Seattle, Washington, United States of America., Hoering A; Cancer Research and Biostatistics, Seattle, Washington, United States of America., Fitch A; Bristol Myers Squibb, Seattle, Washington, United States of America., Newhall K; Sage Bionetworks, Seattle, Washington, United States of America., Barlogie B; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America., Trotter MWB; BMS Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Hershberg RM; Sage Bionetworks, Seattle, Washington, United States of America., Walker BA; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Dervan AP; Sage Bionetworks, Seattle, Washington, United States of America., Ratushny AV; Bristol Myers Squibb, Seattle, Washington, United States of America., Morgan GJ; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.

المصدر: PLoS medicine [PLoS Med] 2020 Nov 04; Vol. 17 (11), pp. e1003323. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*, Bone Marrow/*pathology , Multiple Myeloma/*diagnosis , Multiple Myeloma/*pathology, Adult ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma/drug therapy ; Prognosis ; Tumor Burden

المؤلفون: Phillips KA; Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA.; Philip R. Lee Institute for Health Policy, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Deverka PA; American Institutes for Research, Chapel Hill, North Carolina, USA.; University of North Carolina, Eshelman School of Pharmacy, Center for Pharmacogenomics and Individualized Therapy, Chapel Hill, North Carolina, USA., Trosman JR; Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA.; Center for Business Models in Healthcare, Chicago, Illinois, USA.; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Douglas MP; Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA., Chambers JD; The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies.; Tufts Medical Center, Boston, Massachusetts, USA., Weldon CB; Center for Business Models in Healthcare, Chicago, Illinois, USA.; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Dervan AP; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA.

المصدر: Nature biotechnology [Nat Biotechnol] 2017 Jul 12; Vol. 35 (7), pp. 614-617.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: PubMed not MEDLINE

المؤلفون: Dervan AP; Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA., Deverka PA; American Institutes for Health Research and Innovation, Chapel Hill, North Carolina, USA.; Eshelman School of Pharmacy, Center for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, North Carolina, USA., Trosman JR; Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA.; Center for Business Models in Healthcare, Chicago, Illinois, USA.; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Weldon CB; Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA.; Center for Business Models in Healthcare, Chicago, Illinois, USA.; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Douglas MP; Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA., Phillips KA; Department of Clinical Pharmacy, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), University of California San Francisco, San Francisco, California, USA.; Philip R. Lee Institute for Health Policy, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.

المصدر: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2017 May; Vol. 19 (5), pp. 559-567. Date of Electronic Publication: 2016 Sep 22.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0366 (Electronic) Linking ISSN: 10983600 NLM ISO Abbreviation: Genet Med Subsets: MEDLINE

مواضيع طبية MeSH: Cell-Free Nucleic Acids/*genetics , High-Throughput Nucleotide Sequencing/*methods , Prenatal Diagnosis/*methods , Sequence Analysis, DNA/*methods , Trisomy/*diagnosis, Clinical Decision-Making ; Decision Making ; Down Syndrome/diagnosis ; Down Syndrome/genetics ; Female ; Genetic Testing ; Humans ; Insurance Coverage ; Pregnancy ; Registries ; Trisomy/genetics ; Trisomy 13 Syndrome/diagnosis ; Trisomy 13 Syndrome/genetics ; Trisomy 18 Syndrome/diagnosis ; Trisomy 18 Syndrome/genetics

المؤلفون: Freeman MW; Department of Medicine, Center for Computational & Integrative Biology, Massachusetts General Hospital, Boston, USA. Freeman@molbio.mgh.harvard.edu, Dervan AP

المصدر: Journal of investigative medicine : the official publication of the American Federation for Clinical Research [J Investig Med] 2011 Jun; Vol. 59 (5), pp. 746-51.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9501229 Publication Model: Print Cited Medium: Internet ISSN: 1708-8267 (Electronic) Linking ISSN: 10815589 NLM ISO Abbreviation: J Investig Med Subsets: MEDLINE

مواضيع طبية MeSH: Translational Research, Biomedical/*methods , Translational Research, Biomedical/*trends, Academic Medical Centers ; Biomedical Research/trends ; Drug Design ; Humans ; Industry ; Research Personnel ; Technology Transfer ; Therapeutics/trends ; Translational Research, Biomedical/economics ; Universities